Finalist
Project Twenty21
Summary of work
With Project Twenty21, eligible patients can access affordable medical cannabis treatment, monitored by Drug Science. The project has created the UK’s largest body of evidence for the effectiveness and tolerability of medical cannabis. Drug Science intend that the findings of Project Twenty21 will provide evidence for NHS funding where the benefits of treatment with medicinal cannabis is proven to outweigh the potential risks.
Drug Science works to provide an evidence base free from political or commercial influence, creating the foundation for sensible and effective drug laws, and equipping the public, media and policy makers with the knowledge and resources to enact positive change.
Drug Science is the only completely independent, science-led drugs charity, uniquely bringing together leading drugs experts from a wide range of specialisms to carry out ground-breaking research into drug harms and effects. The Drug Science Scientific Committee is made up of the UKs most accomplished, respected and authoritative individuals in science, academia and policy, united with a passionate belief that the pursuit of knowledge should remain free of all political and commercial interest.
Judges’ comments
Drug Science’s entry had clear, ambitious objectives and showed clarity in addressing all the different partners. The measurement and learnings were used well and the scalability is obvious. They brought awareness to an issue that was less mainstream and they addressed the political societal issue of the use of cannabis in medicine well. A passionate entry!
